Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Wiseman

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Medical Hypotheses|October 19, 2004
Gene therapy for the circumvention of inborn errors of metabolism (IEM) caused by single-nucleotide-polymorphisms (SNPs)Alan Wiseman
Medical Hypotheses|January 18, 2006
Gene-hypermutated isoforms of MYC protein: Tumour-suppressor P-53 protective-initiation of apoptosis that normally prevents Burkitt's lymphoma tumorigenesis can be enhancedAlan Wiseman
Trends in Pharmacological Sciences|February 1, 2003
Do unpredictable toxic side-effects of drugs reflect their promiscuous binding energies?Alan Wiseman
Biotechnology Letters|July 29, 2003
Limitations of in silico predictability of specificity of co-immobilised cytochromes P450 and mimics in food-bioprocessingAlan Wiseman
Trends in Biotechnology|July 13, 2004
Double humanized yeast makes hydrocortisoneAlan Wiseman
Medical Hypotheses|October 4, 2005
Methicillin-resistant Staphylococcus aureus has a beta-lactamase enzyme that can be plasmid-located: ejectable when under attack by adjunct antibioticsAlan Wiseman
Medical Hypotheses|August 25, 2004
Dietary alkyl thiol free radicals (RSS) can be as toxic as reactive oxygen species (ROS)Alan Wiseman
Medical Hypotheses|June 18, 2005
Oestrogen-receptors (ER) are likely to be promiscuous: wider role for oestrogens and mimicsAlan Wiseman
Medical Hypotheses|April 4, 2006
p53 protein or BID protein select the route to either apoptosis (programmed cell death) or to cell cycle arrest opposing carcinogenesis after DNA damage by ROSAlan Wiseman
Medical Hypotheses|January 25, 2006
Crohn's disease leading to bowel cancer may be avoided by consumption of soya isoflavones: adjunct-chemotherapy with oxaliplatinAlan Wiseman
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Medical Hypotheses|October 19, 2004
Gene therapy for the circumvention of inborn errors of metabolism (IEM) caused by single-nucleotide-polymorphisms (SNPs)Alan Wiseman
Medical Hypotheses|January 18, 2006
Gene-hypermutated isoforms of MYC protein: Tumour-suppressor P-53 protective-initiation of apoptosis that normally prevents Burkitt's lymphoma tumorigenesis can be enhancedAlan Wiseman
Trends in Pharmacological Sciences|February 1, 2003
Do unpredictable toxic side-effects of drugs reflect their promiscuous binding energies?Alan Wiseman
Biotechnology Letters|July 29, 2003
Limitations of in silico predictability of specificity of co-immobilised cytochromes P450 and mimics in food-bioprocessingAlan Wiseman
Trends in Biotechnology|July 13, 2004
Double humanized yeast makes hydrocortisoneAlan Wiseman
Medical Hypotheses|October 4, 2005
Methicillin-resistant Staphylococcus aureus has a beta-lactamase enzyme that can be plasmid-located: ejectable when under attack by adjunct antibioticsAlan Wiseman
Medical Hypotheses|August 25, 2004
Dietary alkyl thiol free radicals (RSS) can be as toxic as reactive oxygen species (ROS)Alan Wiseman
Medical Hypotheses|June 18, 2005
Oestrogen-receptors (ER) are likely to be promiscuous: wider role for oestrogens and mimicsAlan Wiseman
Medical Hypotheses|April 4, 2006
p53 protein or BID protein select the route to either apoptosis (programmed cell death) or to cell cycle arrest opposing carcinogenesis after DNA damage by ROSAlan Wiseman
Medical Hypotheses|January 25, 2006
Crohn's disease leading to bowel cancer may be avoided by consumption of soya isoflavones: adjunct-chemotherapy with oxaliplatinAlan Wiseman
Pageof 3